Antibacterial activity of moxifloxacin on bacteria associated with periodontitis within a biofilm

Journal of Medical Microbiology

Volumn 63, Issue PART 2, 2014, Pages 284-292

  Tsaousoglou, Phoebus ^a   Nietzsche, Sandor ^b   Cachovan, Georg ^c   Sculean, Anton ^a   Eick, Sigrun ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b JENA UNIVERSITY HOSPITAL   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; MOXIFLOXACIN; OFLOXACIN;

ACTINOMYCES NAESLUNDII; AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ANAEROBE; ANAEROBIC METABOLISM; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL STRAIN; BACTERIUM CULTURE; BIOFILM; BROTH DILUTION; CAMPYLOBACTER RECTUS; CONCENTRATION RESPONSE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG EXPOSURE; EIKENELLA CORRODENS; EUBACTERIUM; FUSOBACTERIUM NUCLEATUM; IN VITRO STUDY; MICROBIAL POPULATION DYNAMICS; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUTRIENT; PARVIMONAS MICRA; PERIODONTITIS; PHOTOGRAPHY; PLANKTON; PORPHYROMONAS GINGIVALIS; PREVOTELLA INTERMEDIA; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; STREPTOCOCCUS GORDONII; TANNERELLA FORSYTHENSIS; TREPONEMA DENTICOLA;

ANTI-BACTERIAL AGENTS; AZA COMPOUNDS; BACTERIA; BACTERIAL PHYSIOLOGICAL PHENOMENA; BIOFILMS; DOXYCYCLINE; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; OFLOXACIN; PERIODONTITIS; QUINOLINES;

EID: 84892968101     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.065441-0     Document Type: Article

References (59)

1. Ackermann, G., Schaumann, R., Pless, B., Claros, M. C., Goldstein, E. J. & Rodloff, A. C. (2000). Comparative activity of moxifloxacin in vitro against obligately anaerobic bacteria. Eur J Clin Microbiol Infect Dis 19, 228-232.
2. Anonymous (1996). Consensus report periodontal diseases: patho-genesis and microbial factors. Ann Periodontol 1, 926-932.
3. Apatzidou, D. A. & Kinane, D. F. (2010). Nonsurgical mechanical treatment strategies for periodontal disease. Dent Clin North Am 54, 1-12.
4. Ardila, C. M., Granada, M. I. & Guzmán, I. C. (2010). Antibiotic resistance of subgingival species in chronic periodontitis patients. J Periodontal Res 45, 557-563.
5. Ashimoto, A., Chen, C., Bakker, I. & Slots, J. (1996). Polymerase chain reaction detection of 8 putative periodontal pathogens in subgingival plaque of gingivitis and advanced periodontitis lesions. Oral Microbiol Immunol 11, 266-273.
6. Badet, C. & Quero, F. (2011). The in vitro effect of manuka honeys on growth and adherence of oral bacteria. Anaerobe 17, 19-22.
7. Barman Balfour, J. A. & Wiseman, L. R. (1999). Moxifloxacin. Drugs 57, 363-373, discussion 374.
8. Behra-Miellet, J., Dubreuil, L. & Jumas-Bilak, E. (2002). Antianaerobic activity of moxifloxacin compared with that of ofloxacin, ciprofloxacin, clindamycin, metronidazole and beta-lactams. Int J Antimicrob Agents 20, 366-374.
9. Belibasakis, G. N. & Thurnheer, T. (2013). Validation of antibiotic efficacy on in vitro subgingival biofilms. J Periodontol 1-8.
10. Beringer, P. M., Owens, H., Nguyen, A., Benitez, D., Rao, A. & D'Argenio, D. Z. (2012). Pharmacokinetics of doxycycline in adults with cystic fibrosis. Antimicrob Agents Chemother 56, 70-74.
11. Bland, P. S., Goodson, J. M., Gunsolley, J. C., Grossi, S. G., Otomo-Corgel, J., Doherty, F. & Comiskey, J. L. (2010). Association of antimicrobial and clinical efficacy: periodontitis therapy with minocycline microspheres. J Int Acad Periodontol 12, 11-19.
12. Bosco, J. M., Lopes, B. M., Bosco, A. F., Spolidorio, D. M. & Marcantonio, R. A. (2009). Local application of tetracycline solution with a microbrush: an alternative treatment for persistent period-ontitis. Quintessence Int 40, 29-40.
13. Cachovan, G., Böger, R. H., Giersdorf, I., Hallier, O., Streichert, T., Haddad, M., Platzer, U., Schön, G., Wegscheider, K. & Sobottka, I. (2011). Comparative efficacy and safety of moxifloxacin and clindamycin in the treatment of odontogenic abscesses and inflammatory infiltrates: a phase II, double-blind, randomized trial. Antimicrob Agents Chemother 55, 1142-1147.
14. Dalhoff, A. & Schmitz, F. J. (2003). In vitro antibacterial activity and pharmacodynamics of new quinolones. Eur J Clin Microbiol Infect Dis 22, 203-221.
15. Decker, E. M. (2001). The ability of direct fluorescence-based, two-colour assays to detect different physiological states of oral streptococci. Lett Appl Microbiol 33, 188-192.
16. Di Bonaventura, G., Spedicato, I., D'Antonio, D., Robuffo, I. & Piccolomini, R. (2004). Biofilm formation by Stenotrophomonas maltophilia: modulation by quinolones, trimethoprim-sulfamethoxazole, and ceftazidime. Antimicrob Agents Chemother 48, 151-160.
17. Eick, S. & Pfister, W. (2004). Efficacy of antibiotics against period-ontopathogenic bacteria within epithelial cells: an in vitro study. J Periodontol 75, 1327-1334.
18. Eick, S., Schmitt, A., Sachse, S., Schmidt, K. H. & Pfister, W. (2004a). In vitro antibacterial activity of fluoroquinolones against Porphyromonas gingivalis strains. J Antimicrob Chemother 54, 553-556.
19. Eick, S., Seltmann, T. & Pfister, W. (2004b). Efficacy of antibiotics to strains of periodontopathogenic bacteria within a single species biofilm - an in vitro study. J Clin Periodontol 31, 376-383.
20. Eick, S., Straube, A., Guentsch, A., Pfister, W. & Jentsch, H. (2011). Comparison of real-time polymerase chain reaction and DNA-strip technology in microbiological evaluation of periodontitis treatment. Diagn Microbiol Infect Dis 69, 12-20.
21. EUCAST (2013). Breakpoint Tables for Interpretation of MICs and Zone Diameters. Version 3.0 b. European Committee on Antimicrobial Susceptibility Testing.
22. Feres, M., Haffajee, A. D., Allard, K., Som, S., Goodson, J. M. & Socransky, S. S. (2002). Antibiotic resistance of subgingival species during and after antibiotic therapy. J Clin Periodontol 29, 724-735.
23. Flemmig, T. F., Petersilka, G., Völp, A., Gravemeier, M., Zilly, M., Mross, D., Prior, K., Yamamoto, J. & Beikler, T. (2011). Efficacy and safety of adjunctive local moxifloxacin delivery in the treatment of periodontitis. J Periodontol 82, 96-105.
24. Goodson, J. M. (2003). Gingival crevice fluid flow. Periodontol 2000 31, 43-54.
25. Guentsch, A., Jentsch, H., Pfister, W., Hoffmann, T. & Eick, S. (2008). Moxifloxacin as an adjunctive antibiotic in the treatment of severe chronic periodontitis. J Periodontol 79, 1894-1903.
26. Guo, Y., Nguyen, K. A. & Potempa, J. (2010). Dichotomy of gingipains action as virulence factors: from cleaving substrates with the precision of a surgeon's knife to a meat chopper-like brutal degradation of proteins. Periodontol 2000 54, 15-44.
27. Haas, A. N., de Castro, G. D., Moreno, T., Susin, C., Albandar, J. M., Oppermann, R. V. & Rösing, C. K. (2008). Azithromycin as an adjunctive treatment of aggressive periodontitis: 12-months randomized clinical trial. J Clin Periodontol 35, 696-704.
28. Han, B., Emingil, G., Ozdemir, G., Tervahartiala, T., Vural, C., Atilla, G., Baylas, H. & Sorsa, T. (2012). Azithromycin as an adjunctive treatment of generalized severe chronic periodontitis: clinical, microbiologic, and biochemical parameters. J Periodontol 83, 1480-1491.
29. Hardy, D., Amsterdam, D., Mandell, L. A. & Rotstein, C. (2000). Comparative in vitro activities of ciprofloxacin, gemifloxacin, grepafloxacin, moxifloxacin, ofloxacin, sparfloxacin, trovafloxacin, and other antimicrobial agents against bloodstream isolates of Gram-positive cocci. Antimicrob Agents Chemother 44, 802-805.
30. Henderson, B., Nair, S. P., Ward, J. M. & Wilson, M. (2003). Molecular pathogenicity of the oral opportunistic pathogen Actinobacillus actinomycetemcomitans. Annu Rev Microbiol 57, 29-55.
31. Herrera, D., Alonso, B., León, R., Roldán, S. & Sanz, M. (2008). Antimicrobial therapy in periodontitis: the use of systemic antimicrobials against the subgingival biofilm. J Clin Periodontol 35 (Suppl), 45-66.
32. Higashi, K., Seike, M., Mitani, Y., Morisaki, K., Hayashi, S., Kitamura, M., Fujimoto, N., Kimura, S., Ebisu, S. & Okada, H. (1989). Concentration of ofloxacin in human gingival crevicular fluid after oral administration of Tarivid. J Periodontal Res 24, 409-411.
33. Hofer, D., Meier, A., Sener, B., Guggenheim, B., Attin, T. & Schmidlin, P. R. (2011). Biofilm reduction and staining potential of a 0.05% chlorhexidine rinse containing essential oils. Int J Dent Hyg 9, 60-67.
34. Høiby, N., Bjarnsholt, T., Givskov, M., Molin, S. & Ciofu, O. (2010). Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 35, 322-332.
35. Kleinfelder, J. W., Mueller, R. F. & Lange, D. E. (2000). Fluoroquinolones in the treatment of Actinobacillus actinomycetem-comitans-associated periodontitis. J Periodontol 71, 202-208.
36. Kolenbrander, P. E. (2000). Oral microbial communities: biofilms, interactions, and genetic systems. Annu Rev Microbiol 54, 413-437.
37. Kolenbrander, P. E., Palmer, R. J., Jr, Periasamy, S. & Jakubovics, N. S. (2010). Oral multispecies biofilm development and the key role of cell-cell distance. Nat Rev Microbiol 8, 471-480.
38. Kuck, E. M., Bouter, K. P., Hoekstra, J. B., Conemans, J. M. & Diepersloot, R. J. (1998). Tissue concentrations after a single-dose, orally administered ofloxacin in patients with diabetic foot infections. Foot Ankle Int 19, 38-40.
39. Mouratidou, A., Karbach, J., d'Hoedt, B. & Al-Nawas, B. (2011). Antibiotic susceptibility of cocultures in polymicrobial infections such as peri-implantitis or periodontitis: an in vitro model. J Periodontol 82, 1360-1366.
40. Müller, H. P., Heinecke, A., Borneff, M., Kiencke, C., Knopf, A. & Pohl, S. (1998). Eradication of Actinobacillus actinomycetemcomitans from the oral cavity in adult periodontitis. J Periodontal Res 33, 49-58.
41. Pascual, A., García, I., Ballesta, S. & Perea, E. J. (1999). Uptake and intracellular activity of moxifloxacin in human neutrophils and tissue-cultured epithelial cells. Antimicrob Agents Chemother 43, 12-15.
42. Roveta, S., Schito, A. M., Marchese, A. & Schito, G. C. (2007). Activity of moxifloxacin on biofilms produced in vitro by bacterial pathogens involved in acute exacerbations of chronic bronchitis. Int J Antimicrob Agents 30, 415-421.
43. Sgolastra, F., Petrucci, A., Gatto, R. & Monaco, A. (2011). Effectiveness of systemic amoxicillin/metronidazole as an adjunctive therapy to full-mouth scaling and root planing in the treatment of aggressive periodontitis: a systematic review and meta-analysis. J Periodontol 83, 731-743.
44. Sgolastra, F., Gatto, R., Petrucci, A. & Monaco, A. (2012). Effectiveness of systemic amoxicillin/metronidazole as adjunctive therapy to scaling and root planing in the treatment of chronic periodontitis: a systematic review and meta-analysis. J Periodontol 83, 1257-1269.
45. Shchipkova, A. Y., Nagaraja, H. N. & Kumar, P. S. (2010). Subgingival microbial profiles of smokers with periodontitis. J Dent Res 89, 1247-1253.
46. Socransky, S. S. & Haffajee, A. D. (2005). Periodontal microbial ecology. Periodontol 2000 38, 135-187.
47. Speciale, A., Musumeci, R., Blandino, G., Milazzo, I., Caccamo, F. & Nicoletti, G. (2002). Minimal inhibitory concentrations and time-kill determination of moxifloxacin against aerobic and anaerobic isolates. Int J Antimicrob Agents 19, 111-118.
48. Stass, H., Dalhoff, A., Kubitza, D. & Schühly, U. (1998). Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects. Antimicrob Agents Chemother 42, 2060-2065.
49. Stoller, N. H., Johnson, L. R., Trapnell, S., Harrold, C. Q. & Garrett, S. (1998). The pharmacokinetic profile of a biodegradable controlled-release delivery system containing doxycycline compared to system-ically delivered doxycycline in gingival crevicular fluid, saliva, and serum. J Periodontol 69, 1085-1091.
50. Ta, C. N., He, L., Nguyen, E. & De Kaspar, H. M. (2006). Prospective randomized study determining whether a 3-day application of ofloxacin results in the selection of fluoroquinolone-resistant coagulase-negative Staphylococcus. Eur J Ophthalmol 16, 359-364.
51. Takahashi, N., Ishihara, K., Kato, T. & Okuda, K. (2007). Susceptibility of Actinobacillus actinomycetemcomitans to six antibiotics decreases as biofilm matures. J Antimicrob Chemother 59, 59-65.
52. Tomasi, C. & Wennström, J. L. (2011). Locally delivered doxycycline as an adjunct to mechanical debridement at retreatment of periodontal pockets: outcome at furcation sites. J Periodontol 82, 210-218.
53. Tonetti, M. S., Lang, N. P., Cortellini, P., Suvan, J. E., Eickholz, P., Fourmousis, I., Topoll, H., Vangsted, T. & Wallkamm, B. (2012). Effects of a single topical doxycycline administration adjunctive to mechanical debridement in patients with persistent/recurrent period-ontitis but acceptable oral hygiene during supportive periodontal therapy. J Clin Periodontol 39, 475-482.
54. Torum, B., Block, S. L., Avila, H., Montiel, F., Oliva, A., Quintanilla, W., Duncanson, F., Cantrell, H. F., Riefler, J. & other authors (2004). Efficacy of ofloxacin otic solution once daily for 7 days in the treatment of otitis externa: a multicenter, open-label, phase III trial. Clin Ther 26, 1046-1054.
55. Van der Weijden, G. A. & Timmerman, M. F. (2002). A systematic review on the clinical efficacy of subgingival debridement in the treatment of chronic periodontitis. J Clin Periodontol 29 (Suppl 3), 55-71.
56. van Winkelhoff, A. J., Herrera, D., Oteo, A. & Sanz, M. (2005). Antimicrobial profiles of periodontal pathogens isolated from periodontitis patients in The Netherlands and Spain. J Clin Periodontol 32, 893-898.
57. Yamagami, H., Takamori, A., Sakamoto, T. & Okada, H. (1992). Intrapocket chemotherapy in adult periodontitis using a new controlled-release insert containing ofloxacin (PT-01). J Periodontol 63, 2-6.
58. Yashima, A., Gomi, K., Maeda, N. & Arai, T. (2009). One-stage full-mouth versus partial-mouth scaling and root planing during the effective half-life of systemically administered azithromycin. J Periodontol 80, 1406-1413.
59. Zilberman, M. & Elsner, J. J. (2008). Antibiotic-eluting medical devices for various applications. J Control Release 130, 202-215.